Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

87.24
Delayed Data
As of Sep 02
 +2.81 / +3.33%
Today’s Change
41.86
Today|||52-Week Range
138.85
-22.13%
Year-to-Date
No recent news for Agios Pharmaceuticals Inc.

Today’s Trading

Previous close84.43
Today’s open86.17
Day’s range84.04 - 87.45
Volume314,918
Average volume (3 months)603,949
Market cap$3.2B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+43.82%
Earnings growth (this year)-39.03%
Earnings growth (next 5 years)--
Revenue growth (last year)+155.82%
P/E ratioNM
Price/Sales57.71
Price/Book7.38

Competitors

----
EXAMExamWorks Group Inc-0.59-1.69%
GNMKGenMark Diagnostics ...+0.15+1.55%
NEONeogenomics Inc+0.54+9.09%
Data as of 4:02pm ET, 09/02/2015

Financials

Next reporting dateNovember 6, 2015
EPS forecast (this quarter)-$0.91
Annual revenue (last year)$65.4M
Annual profit (last year)-$53.5M
Net profit margin-81.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Operating Officer
John Duncan Higgons
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers